BioLife Solutions (BLFS) Company Gross Revenue

Symbol and logo of brand BioLife Solutions Inc (BLFS)

BioLife Solutions, Inc. (BLFS) creates critical infrastructure for regenerative medicine by combining cryogenic equipment with specialized media. The company's sales profile reflects the dynamics of this demand, where 0.10 represents the current metric. However, volatility in biotech investments and R&D costs create risks for margins. Consumables provide stable income, acting as a consistent cash generator.

BLFS BioLife: Company Revenue in the range 07/04/2022 - 10/18/2026

Analytical breakdowns for BioLife Solutions (BLFS)

- share price and expert price forecast:
Summary company analysis:BioLife Solutions, Inc.
Core merchandise of biolifesolutions.com

BioLife Solutions, Inc. (BLFS) utilizes robotic production of cryopreservation tools to ensure high assembly precision and supply scalability. This sales data set reflects the company's actual daily cash inflows from customers. This metric allows for a real-time assessment of the issuer's commercial activity, bypassing the time lags associated with quarterly reports. The steady growth of this indicator confirms the demand for biotech solutions, while positive revenue dynamics serve as the foundation for the stability of market quotes.

Analysis of competing companies

TEM: Company Sales Revenue|Company Revenue Qiagen N.V. (QGEN)|Company Gross Revenue ionispharma.com|Company Revenue Repligen RGEN|Avidity Biosciences Inc (RNA) - Company Total Revenue|CRSP - Company Revenue|WGS: Company Revenue|RARE (Ultragenyx Pharmaceutical) - Company Sales|beamtx.com (BEAM) - Revenue and Sales Volume|Company Sales SRPT|TWST (Twist Bioscience Inc) - Company Total Sales|Revenue and Sales Volume TXG|Company Gross Revenue Intellia Corp|Company Revenue Stoke Therapeutics STOK|wavelifesciences.com (WVE) - Company Total Revenue|MAZE - Company Revenue|SION (Sionna Therapeutics, Inc.) - Company Sales Volume|Prime Medicine Corp (PRME) - Company Revenue|TSHA - Company Gross Revenue|Company Sales QURE|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Biosciences Inc|Company Revenue Ocugen Corp OCGN|PACB: Company Sales Volume|Benitec Biopharma Inc. - Revenue and Sales Volume|designtx.com (DSGN) - Company Sales|RCKT (Rocket Pharmaceuticals, Inc.) - Company Sales|FDMT - Company Gross Revenue|LXEO (Lexeo Therapeutics Inc.) - Revenue and Sales Volume|Company Revenue KRRO|Company Revenue Editas Medicine, Inc. (EDIT)|Company Revenue SLN (silence-therapeutics.com)|Revenue and Sales Volume PRQR (ProQR Therapeutics)|CDXS (Codexis Inc) - Company Annual Revenue|SGMO - Company Revenue|Company Gross Revenue Nautilus Biotechnology NAUT|MGX: Revenue and Sales Volume|Company Sales Volume DTIL|Company Revenue Generation Bio Co|Company Sales Volume BOLD (Boundless Bio Inc.)|Revenue and Sales Volume XCUR|Revenue and Sales Volume imunon.com (IMNN)|Revenue and Sales Volume PHIO (Phio Pharmaceuticals Corp.)|Mustang Bio Inc - Company Revenue|TransCode - Revenue and Sales Volume|Company Gross Revenue Bionano Genomics, Inc. BNGO|Applied DNA (APDN) - Company Revenue|Company Total Revenue bluebird bio, Inc (BLUE)|Company Revenue ImmunoPrecise Antibodies Ltd|Company Revenue OMGA|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics, Inc.|Revenue and Sales Volume SYRS (Syros)|TBIO (Telesis Bio, Inc) - Company Annual Revenue|TRACON Pharmaceuticals - Revenue and Sales Volume|Company Total Revenue unitybiotechnology.com